InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the detailed record of transactions filed by Violin Jonathan, Director. Director active across 2 companies, notably Astria Therapeutics, Inc.. Cumulatively, 10 filings have been logged. Total volume traded: €2.1m. The latest transaction was disclosed on 1 June 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
€343,52830,000 shares@ €11.45090.020% mcap16.8% of flow
Common Stock
SEC:0000899243-22-020717:0·
€372,25030,000 shares@ €12.40830.021% mcap18.2% of flow
Common Stock
SEC:0000899243-22-016657:0·
€451,11326,400 shares@ €17.08760.026% mcap22.0% of flow
Common Stock
SEC:0000899243-22-013858:0·
€300,19018,894 shares@ €15.88810.017% mcap14.6% of flow
Common Stock
SEC:0000899243-22-009096:0·
€291,62316,751 shares@ €17.40930.017% mcap100.0% of flow
Common Stock
SEC:0000899243-22-004665·
€291,62316,751 shares@ €17.40930.017% mcap14.2% of flow
Common Stock
SEC:0000899243-22-004665:0·
0627,564 shares0
Common Stock
SEC:0000899243-21-047801·
0627,564 shares0
Common Stock
SEC:0000899243-21-047801:0·
0263,321 shares0
Common Stock
SEC:0001104659-21-118359·
0263,321 shares0
Common Stock
SEC:0001104659-21-118359:0·
10 of 10 declarations
About Violin Jonathan
Jonathan Violin is the President and Director at Astria Therapeutics, Inc. and Viridian Therapeutics, Inc. He plays a key role in the strategic direction of these companies, overseeing operations and the development of new products. Jonathan contributes to guiding research and development initiatives.
